Picture of Larimar Therapeutics logo

LRMR — Larimar Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Brief: Larimar Therapeutics Q1 Net Income USD -29.613 Million

May 14 (Reuters) - Larimar Therapeutics Q1 income from operations USD -31.117 million.

Q1 operating expenses USD 31.117 million

Q1 EPS USD -0.31

Recent news on Larimar Therapeutics

See all news